# Strategic Feedback — GPT-5.4 (R1)

**Role:** Journal editor (AER perspective)
**Model:** openai/gpt-5.4
**Timestamp:** 2026-03-09T03:01:52.064539
**Route:** OpenRouter + LaTeX
**Tokens:** 18996 in / 4009 out
**Response SHA256:** 4e3bc7a7f24456b3

---

## 1. THE ELEVATOR PITCH

This paper asks whether state adoption of red flag laws actually reduces total suicide deaths, or whether it merely changes the method people use. Using staggered state adoption of ERPO laws, the paper’s headline claim is that adoption does not produce a detectable reduction in population-level suicide, and that older TWFE approaches would have misleadingly suggested the opposite.

A busy economist should care because this is, in principle, a high-stakes question about whether a prominent, politically salient targeted gun policy saves lives at scale — and because it speaks to the broader issue of when “means restriction” changes total mortality versus simply reallocating behavior.

**Does the paper itself articulate this pitch clearly in the first two paragraphs?** Not quite. The introduction opens with background facts about suicide lethality and then moves into a policy description. That is competent, but the real hook is buried: this is not just “a paper on ERPOs,” it is a paper about whether a highly targeted intervention can move aggregate mortality, and whether the literature may have drawn the wrong conclusion from older panel methods. The introduction takes too long to get to that point.

**What the first two paragraphs should say instead:**

> Red flag laws have become one of the most prominent U.S. policy responses to suicide and gun violence. Their logic is compelling: if suicidal crises are brief and firearms are unusually lethal, temporarily removing guns from high-risk individuals should reduce deaths. But at the population level, that implication is not automatic. Red flag laws may be used too rarely to move aggregate mortality, and any reduction in firearm suicide may be offset by substitution toward other methods.
>
> This paper asks a simple policy question with unusually high stakes: when states adopt red flag laws, do total suicides fall? Using staggered adoption across U.S. states from 1999 to 2024, I find no detectable reduction in total suicide rates from ERPO adoption at the state level. I also show that the conventional two-way fixed effects approach yields the opposite answer, suggesting that part of the existing policy narrative may rest on now-known weaknesses in staggered-adoption designs.

That is the pitch. Lead with the world question, then the surprising answer, then the methods wrinkle.

---

## 2. CONTRIBUTION CLARITY

**One-sentence contribution:**  
The paper argues that state adoption of ERPO laws has not detectably reduced total suicide mortality at the population level, and that conventional TWFE estimates overstate or even reverse the sign of the policy’s effect.

### Is this contribution clearly differentiated from the closest 3-4 papers?
Somewhat, but not sharply enough. The paper names prior ERPO studies and says it is the first to apply heterogeneity-robust staggered DiD over the long panel. That is a method-based differentiation. Useful, but not sufficient for AER-level positioning.

Right now the contribution risks sounding like: “another policy DiD, but with modern estimators.” That is not enough. The stronger distinction is substantive: prior evidence mostly tells us either about individual cases or about method-specific outcomes in selected states; this paper asks whether adoption of the law moves **total mortality at the state level**, which is the policy margin legislators actually care about.

### Is the contribution framed as answering a question about the WORLD, or filling a gap in a LITERATURE?
It is mixed, leaning too much toward literature/method gap. The paper repeatedly emphasizes “first application of Callaway-Sant’Anna to ERPOs” and “TWFE bias.” That is not the strongest way to sell it. The stronger framing is:

- Governments adopted a policy to save lives.
- The relevant policy question is whether adoption changes total deaths, not whether a selected set of people subject to petitions looks safer afterward.
- The answer appears to be no detectable aggregate effect under current implementation.

That is a world question. The paper should stay there.

### Could a smart economist who reads the introduction explain to a colleague what’s new?
At present, they might say: “It’s a staggered DiD paper on red flag laws showing null effects and warning against TWFE.” That is too close to “another DiD paper about X.”

What you want them to say is: “Interesting — despite strong theory and supportive case-level evidence, red flag laws don’t seem to reduce total suicides at the state level, which suggests the policy may be too targeted or too lightly used to matter in aggregate.”

That is much better.

### What would make this contribution bigger?
Most importantly, the paper needs a **bigger substantive frame**, not more econometric throat-clearing. Specific ways to enlarge it:

1. **Center implementation intensity rather than adoption.**  
   The paper itself repeatedly says adoption is not utilization. That is the obvious next step and the paper knows it. If the important margin is petitions/orders per capita, then adoption alone may be too crude to answer the meaningful policy question. As currently framed, the paper is at risk of answering a somewhat mechanical question (“does a law on the books matter?”) rather than the economically important one (“does actual use of this intervention save lives?”).

2. **Make the “individual efficacy vs population efficacy” gap the main contribution.**  
   This is the paper’s most interesting idea. Economists care about scaling. Many interventions work in selected cases and fail in aggregate because take-up, targeting, equilibrium responses, or implementation are weak. Framing ERPOs as a case study in the wedge between micro efficacy and macro impact would broaden the paper beyond gun policy.

3. **Tie the paper more explicitly to means-restriction and targeted-prevention literatures.**  
   The current means-substitution angle is in the title, but the paper ultimately cannot say much about substitution because its mechanism exercise is underpowered and inconclusive. So the current title somewhat overpromises. If means substitution cannot be answered cleanly, the paper should not hinge its strategic positioning on that question.

4. **Potentially broaden outcomes beyond suicide.**  
   ERPOs are also justified as preventing interpersonal violence and mass shootings. If those outcomes are too rare for credible state-level analysis, then fine — but the paper should directly acknowledge that it is speaking only to one margin of the policy case. Otherwise it risks understating the policy’s intended domain.

---

## 3. LITERATURE POSITIONING

### Closest neighbors
The most obvious neighbors are:

1. **Kivisto and Phalen (2018)** on Connecticut and Indiana red flag laws and suicide.
2. **Humphreys, Gasparrini, Wiebe (2019)** on Florida’s implementation and firearm suicides.
3. **Swanson et al. (2014, 2019)** on ERPO/risk-warrant implementation and respondent outcomes in Connecticut/Indiana.
4. The broader **means-restriction / suicide prevention** literature:
   - Mann et al. (2005)
   - Daigle (2005)
   - Barber and Miller (if cited in this area)
5. The recent **staggered DiD methods** literature:
   - Callaway and Sant’Anna (2021)
   - Goodman-Bacon (2021)
   - de Chaisemartin and D’Haultfoeuille (2020)
   - Roth et al. on event-study issues

### How should the paper position itself relative to those neighbors?
Mostly **build on and reinterpret**, not attack.

- Relative to **ERPO case studies**: “Those papers are informative about selected states or selected individuals; this paper asks whether the policy changes population mortality when rolled out across states.”
- Relative to **means restriction**: “This paper tests whether a targeted firearm-removal policy generates aggregate mortality changes consistent with means restriction.”
- Relative to **modern DiD**: “This paper uses updated tools to revisit a policy question where older methods may have overstated effects.”

It should not overplay a takedown of the earlier literature. The current draft occasionally sounds eager to invalidate prior work on method grounds. That is not the strongest stance. Better to say earlier work answered different questions on different margins.

### Is it positioned too narrowly or too broadly?
Currently, oddly, both.

- **Too narrowly** in the sense that it often reads like a specialist note on ERPOs and staggered DiD.
- **Too broadly** in that the title and framing invoke “means substitution,” but the paper does not actually resolve that question.

The sweet spot is: **a broad paper about the limits of targeted means-restriction policies when judged by aggregate mortality** using ERPOs as the setting.

### What literature does the paper seem unaware of, or not fully engaging?
It should speak more to:

- **Policy implementation / state capacity / take-up**: laws on the books vs active use.
- **Targeted interventions vs population outcomes**: a classic economics scaling problem.
- **Health policy evaluation of extensive-margin adoption vs intensive-margin use**.
- Possibly **crime/incapacitation literature** where targeted removal of means/opportunity may matter only if intensity is high enough.

The paper has a public-health bibliography. For AER, it needs a more economics-facing conversation about scaling, treatment intensity, and policy design.

### Is it having the right conversation?
Not yet. It is currently having too much of a conversation about estimator choice. The more impactful conversation is:

- Why do policies with compelling individual-level logic fail to move aggregate outcomes?
- What is learned when adoption has no detectable effect but implementation intensity likely varies massively?
- How should economists think about targeted risk-based policies whose true treatment is sparse and endogenous utilization?

That is a better conversation, and a more AER-relevant one.

---

## 4. NARRATIVE ARC

### Setup
ERPO laws spread rapidly because they offer a politically salient, targeted way to prevent suicides by temporarily removing firearms from high-risk individuals. Given the short duration of many suicidal crises and the lethality of firearms, there is a strong intuitive case that these laws should save lives.

### Tension
But two reasons create genuine uncertainty: first, people may substitute to other methods; second, and probably more important, a law may exist on paper while being used too infrequently or unevenly to affect state-level mortality. Meanwhile, prior evidence is mostly from case studies or older panel methods that may not capture the population-level effect reliably.

### Resolution
Using state adoption over 1999–2024, the paper finds no detectable reduction in total suicides from ERPO adoption at the state level.

### Implications
The implication is not necessarily that ERPOs never help, but that adoption alone may be insufficient to move aggregate mortality under current implementation patterns. More broadly, the paper suggests policymakers should distinguish sharply between a policy’s efficacy for treated individuals and its impact at population scale.

### Does the paper have a clear narrative arc?
There is the skeleton of one, but the paper is still too much a **collection of results and caveats** rather than a disciplined story. The current order is:

- Policy background
- Methods justification
- Null main result
- TWFE sign reversal
- Inconclusive mechanism decomposition
- Limitations

That sequence leaves the reader unsure what the paper is *really* about. Is it about ERPO effectiveness? Means substitution? TWFE bias? Implementation intensity? All four are present, and that dilutes the narrative.

### What story should it be telling?
The cleanest story is:

1. **ERPOs are a targeted means-restriction policy that should, in theory, save lives.**
2. **The relevant policy test is whether adoption reduces total suicide deaths.**
3. **At the state level, it does not detectably do so.**
4. **This likely reflects the gap between a policy being available and being used intensively enough to matter.**
5. **Conventional panel methods can misleadingly suggest success, helping explain why policy confidence may outrun population evidence.**

That is the story. The means-substitution material should be demoted unless the paper can genuinely deliver on it.

---

## 5. THE "SO WHAT?" TEST

### What fact would I lead with?
I would lead with: **“Despite strong theory and favorable case-level evidence, state adoption of red flag laws does not appear to reduce total suicide rates at the population level.”**

That is the attention-getter.

### Would people lean in or reach for their phones?
They would lean in — **if** it is presented as a surprising disconnect between intuitive policy logic and aggregate evidence. They would reach for their phones if it is presented as “we use Callaway-Sant’Anna instead of TWFE and get a null.”

### What follow-up question would they ask?
Immediately: **“Is that because the laws don’t work, or because they’re barely used?”**

That is the key follow-up, and the paper currently cannot answer it decisively. That is the central strategic weakness.

### If the findings are null or modest, is the null itself interesting?
Yes, potentially very interesting. But the paper needs to make a sharper case that the null is informative rather than merely inconclusive.

At the moment it does half of this well: it emphasizes that the confidence interval rules out large beneficial effects. That is useful. But it also hedges heavily, to the point that the reader may conclude the paper is simply underpowered or compromised by data limitations. A good null paper must project confidence about **what has been learned**.

What has been learned here is not “nothing happened.” It is closer to:

- If ERPO adoption has any effect on total suicide mortality, it is not large at the state-year aggregate level under current usage patterns.
- That is already policy relevant, because legislation is often sold as if adoption itself should visibly save lives.

That needs to be said more cleanly and with less apologetic tone.

---

## 6. STRUCTURAL SUGGESTIONS

### What would make it read better?

1. **Shorten the institutional background substantially.**  
   It is too long for what the paper ultimately does. The detailed ERPO process, petition rules, and ex parte hearing descriptions are more than the main text needs. Compress to 2–3 paragraphs and move the rest to an appendix or brief background box.

2. **Move the main result even earlier.**  
   The reader should know by page 2 or 3 that the paper finds no detectable aggregate effect. Right now the intro gets there, but then the paper spends many pages on setup before resuming the central point.

3. **Demote the mechanism decomposition.**  
   As currently presented, it is too weak to carry the “means substitution” promise. It may belong as a brief exploratory section or appendix, not as a coequal pillar of the paper.

4. **Demote some of the methodological exposition.**  
   The paper spends a lot of text explaining why TWFE can be biased. For an AER audience, this is already familiar. One concise paragraph is enough in the main text; details can go to an appendix.

5. **Cut repetitive caveating.**  
   The draft repeatedly says the mechanism exercise is underpowered, the placebo is imprecise, the COVID period is noisy, etc. Some of that is necessary, but the accumulation drains momentum. State limitations once crisply rather than re-litigating them in each subsection.

6. **Rebuild the results section around 2 facts, not 6 exercises.**  
   Suggested structure:
   - Main result: no detectable effect on total suicide.
   - Diagnostic contrast: TWFE would have implied a reduction.
   - Interpretation: adoption vs utilization; why aggregate null and individual efficacy can coexist.
   Everything else becomes support.

7. **Rewrite the conclusion to add value.**  
   The current conclusion mostly summarizes. It should end on a broader lesson: targeted policies can be individually valuable yet too weakly deployed to move population outcomes, and empirical designs based on adoption may miss the economically relevant treatment margin.

### Are there results buried in robustness that should be in the main text?
The most important buried insight is the paper’s own recognition that **implementation intensity is probably the real treatment margin**. That should not appear mainly as caveat/discussion; it should be central from the beginning.

### Is the conclusion adding value or just summarizing?
Mostly summarizing. It should make one strong conceptual point rather than recapping coefficients.

---

## 7. WHAT WOULD MAKE THIS AN AER PAPER?

Be honest: in current form, this is **not yet an AER paper**. The issue is less technical competence than strategic ambition.

### What is the gap?

#### 1. Framing problem
Yes. This is the biggest one. The paper currently sells itself as:
- ERPO paper
- means substitution paper
- modern DiD paper
- TWFE warning paper

That is too many identities, none fully dominant.

The strongest identity is: **a paper about why a targeted, intuitively powerful policy may fail to move aggregate mortality, and what that implies about policy evaluation and implementation.**

#### 2. Scope problem
Also yes. The paper’s central estimand is adoption, but the discussion itself insists that utilization intensity matters. That creates a mismatch between the question readers care about and the one the paper can answer. For a top general-interest journal, that mismatch is costly.

#### 3. Novelty problem
Partly. Re-estimating a known policy question with a better staggered-DiD estimator is not enough by itself. The null result helps, but absent a deeper substantive payoff, this could still read as incremental.

#### 4. Ambition problem
Yes. The paper is careful, but safe. It stops at “no detectable effect of adoption.” The top 10 people in this field will ask: what does this teach us beyond that? Why does adoption fail? What margin matters? How should policy be redesigned or evaluated differently?

### Single most impactful piece of advice
**Reframe the paper around the gap between individual-level efficacy and population-level impact, and make “adoption is the wrong treatment margin; utilization intensity is the real one” the central economic insight rather than a caveat.**

If the author can only change one thing, that is it.

A corollary: the current title likely needs revision. “Do Red Flag Laws Save Lives or Shift Deaths?” promises a clean means-substitution answer the paper does not really deliver. A better title would foreground aggregate impact and implementation scale.

Example of a stronger strategic title:
**“Do Red Flag Laws Reduce Suicide at Scale? Population Effects of ERPO Adoption”**  
or  
**“From Targeted Intervention to Population Impact: Evidence on ERPO Laws and Suicide”**

---

### Strategic Assessment

- **Current framing quality:** Needs rethinking
- **Contribution clarity:** Somewhat fuzzy
- **Literature positioning:** Could be stronger
- **Narrative arc:** Serviceable
- **AER distance:** Medium-Far
- **Single biggest improvement:** Recenter the paper on the substantive puzzle that ERPOs may help selected individuals yet fail to reduce aggregate suicide because adoption is a poor proxy for policy intensity.